I-Tirzepatide CAS:2023788-19-2 Umthengisi woMvelisi Umfanekiso oPhambili

Umthengisi weTirzepatide CAS:2023788-19-2

I-Tirzepatide yaphuhliswa njenge-agonist ezimbini kwi-GLP-1 kunye ne-gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Ngokufanayo ne-GLP-1, i-GIP yi-incretin hormone esebenza ukukhuthaza ukukhutshwa kwe-insulin. I-Tirzepatide ikwisigaba sesi-3 sophuhliso kubantu abadala abatyebe kakhulu okanye abatyebe kakhulu abaneengxaki ezinxulumene nobunzima kwaye okwangoku iphantsi kovavanyo olusemthethweni njengonyango lwabantu abadala abanesifo seswekile sohlobo lwe-2. Ikwaphandwa njengonyango olunokwenzeka lwe-steatohepatitis engeyiyo i-alcoholic (NASH) kunye nokusilela kwentliziyo nge-preserved ejection fraction (HFpEF).

Oda okanye Cela iKoteshini

Iinkcukacha zeMveliso

Iithegi zeMveliso

Ukusetyenziswa kunye nesiphumo

I-Tirzepatide isetyenziswa kunye nokutya okufanelekileyo kunye nenkqubo yokuzilolonga ukulawula iswekile ephezulu yegazi kubantu abanesifo seswekile sohlobo lwesibini. Ukulawula iswekile ephezulu yegazi kunceda ukuthintela ukonakala kwezintso, ubumfama, iingxaki zemithambo-luvo, ukulahleka kwamalungu omzimba, kunye neengxaki zokusebenza ngokwesondo. I-Tirzepatide inomdla omkhulu kwii-receptors ze-GIP kunee-receptors ze-GLP-1, kwaye le ndlela yokuziphatha ye-agonist ezimbini ibonakalisiwe ukuba ibangela ukwehla okukhulu kwe-hyperglycemia xa kuthelekiswa ne-agonist ye-receptor ye-GLP-1 ekhethiweyo. Izifundo zesignali zibonise ukuba oku kungenxa yokuba i-tirzepatide ilingisa izenzo ze-GIP yendalo kwi-receptor ye-GIP.

Isampuli yeMveliso

Ukupakisha imveliso:

Iinkcukacha ezongezelelweyo:

Ukwakhiwa	N / A
Uvavanyo	99%
Inkangeleko	Umgubo omhlophe
Inombolo ye-CAS	2023788-19-2
Ukupakisha	25KG
Beka ubomi kwishelufa	iminyaka eyi-2
Indawo yokugcina izinto	Gcina kwindawo epholileyo neyomileyo
Isiqinisekiso	I-ISO.